These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34428033)

  • 1. Precision Modification of Native Antibodies.
    Wu KL; Yu C; Lee C; Zuo C; Ball ZT; Xiao H
    Bioconjug Chem; 2021 Sep; 32(9):1947-1959. PubMed ID: 34428033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of precision antibody conjugates using proximity-induced chemistry.
    Cao YJ; Yu C; Wu KL; Wang X; Liu D; Tian Z; Zhao L; Qi X; Loredo A; Chung A; Xiao H
    Theranostics; 2021; 11(18):9107-9117. PubMed ID: 34522229
    [No Abstract]   [Full Text] [Related]  

  • 3. Site-specific antibody-drug conjugates: the nexus of bioorthogonal chemistry, protein engineering, and drug development.
    Agarwal P; Bertozzi CR
    Bioconjug Chem; 2015 Feb; 26(2):176-92. PubMed ID: 25494884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids.
    Adumeau P; Sharma SK; Brent C; Zeglis BM
    Mol Imaging Biol; 2016 Apr; 18(2):153-65. PubMed ID: 26754791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proximity-Induced Site-Specific Antibody Conjugation.
    Yu C; Tang J; Loredo A; Chen Y; Jung SY; Jain A; Gordon A; Xiao H
    Bioconjug Chem; 2018 Nov; 29(11):3522-3526. PubMed ID: 30372039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and Glycans.
    Adumeau P; Sharma SK; Brent C; Zeglis BM
    Mol Imaging Biol; 2016 Feb; 18(1):1-17. PubMed ID: 26754790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LASIC: Light Activated Site-Specific Conjugation of Native IgGs.
    Hui JZ; Tamsen S; Song Y; Tsourkas A
    Bioconjug Chem; 2015 Aug; 26(8):1456-60. PubMed ID: 26057140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of site-specific antibody-drug conjugates using unnatural amino acids.
    Axup JY; Bajjuri KM; Ritland M; Hutchins BM; Kim CH; Kazane SA; Halder R; Forsyth JS; Santidrian AF; Stafin K; Lu Y; Tran H; Seller AJ; Biroc SL; Szydlik A; Pinkstaff JK; Tian F; Sinha SC; Felding-Habermann B; Smider VV; Schultz PG
    Proc Natl Acad Sci U S A; 2012 Oct; 109(40):16101-6. PubMed ID: 22988081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering THIOMABs for site-specific conjugation of thiol-reactive linkers.
    Bhakta S; Raab H; Junutula JR
    Methods Mol Biol; 2013; 1045():189-203. PubMed ID: 23913148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity-Directed Site-Specific Protein Labeling and Its Application to Antibody-Drug Conjugates.
    Kim S; Kim S; Kim S; Kim N; Lee SW; Yi H; Lee S; Sim T; Kwon Y; Lee HS
    Adv Sci (Weinh); 2024 Jan; 11(4):e2306401. PubMed ID: 38032124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods to generate site-specific conjugates of antibody and protein.
    Park J; Lee S; Kim Y; Yoo TH
    Bioorg Med Chem; 2021 Jan; 30():115946. PubMed ID: 33360577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-Specific Photocrosslinking to Immunoglobulin G Using Photoreactive Antibody-Binding Domains.
    Zappala F; Tsourkas A
    Methods Mol Biol; 2019; 2033():275-286. PubMed ID: 31332760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of bispecific antibody-protein adducts by site-specific chemo-enzymatic conjugation.
    Bartels L; Ploegh HL; Spits H; Wagner K
    Methods; 2019 Feb; 154():93-101. PubMed ID: 30081077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecularly defined antibody conjugation through a selenocysteine interface.
    Hofer T; Skeffington LR; Chapman CM; Rader C
    Biochemistry; 2009 Dec; 48(50):12047-57. PubMed ID: 19894757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific modification of ED-B-targeting antibody using intein-fusion technology.
    Möhlmann S; Bringmann P; Greven S; Harrenga A
    BMC Biotechnol; 2011 Jul; 11():76. PubMed ID: 21777442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of immunoconjugates using antibody oligosaccharide moieties.
    Vogel CW
    Methods Mol Biol; 2004; 283():87-108. PubMed ID: 15197304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AJICAP: Affinity Peptide Mediated Regiodivergent Functionalization of Native Antibodies.
    Yamada K; Shikida N; Shimbo K; Ito Y; Khedri Z; Matsuda Y; Mendelsohn BA
    Angew Chem Int Ed Engl; 2019 Apr; 58(17):5592-5597. PubMed ID: 30854738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A general approach to site-specific antibody drug conjugates.
    Tian F; Lu Y; Manibusan A; Sellers A; Tran H; Sun Y; Phuong T; Barnett R; Hehli B; Song F; DeGuzman MJ; Ensari S; Pinkstaff JK; Sullivan LM; Biroc SL; Cho H; Schultz PG; DiJoseph J; Dougher M; Ma D; Dushin R; Leal M; Tchistiakova L; Feyfant E; Gerber HP; Sapra P
    Proc Natl Acad Sci U S A; 2014 Feb; 111(5):1766-71. PubMed ID: 24443552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the Development of Site-Specific Antibody-Drug Conjugation.
    Zhou Q; Kim J
    Anticancer Agents Med Chem; 2015; 15(7):828-36. PubMed ID: 25731178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-Specific Antibody Labeling Using Phosphopantetheinyl Transferase-Catalyzed Ligation.
    Grünewald J; Brock A; Geierstanger BH
    Methods Mol Biol; 2019; 2012():237-278. PubMed ID: 31161512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.